Anti-S100A4 monoclonal antibody treatment ameliorates experimental skin fibrosis and SSc-specific transcriptional signatures in human skin: Comment on the targeting S100A4 is helpful in SSc treatment by Trinh-Minh et al.
An-Fang HuangWang-Dong XuPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2024)